올소 프탈알데히드(OPA) 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Ortho Phthalaldehyde Market reached USD 5.9 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2034. This chemical compound, known for its superior disinfectant and antiseptic properties, plays a critical role across various industries. Its widespread use in healthcare, pharmaceuticals, research laboratories, and the chemical sector stems from its high efficacy in sterilization and microbial control. The market is experiencing robust growth due to increasing demand for effective disinfection solutions, driven by heightened awareness of infection prevention and stringent hygiene standards.

Investments in production and supply chains are on the rise, while advancements in formulation techniques are enhancing product efficiency and ensuring compliance with rigorous safety and environmental regulations. The growing emphasis on maintaining hygiene in medical facilities and research environments is accelerating adoption, particularly in developed regions. Additionally, the shift toward safer, less toxic disinfectants is driving a preference for ortho phthalaldehyde over traditional alternatives. Industries are actively exploring innovative applications for this versatile compound, further strengthening its market presence. The market's growth is also supported by the rising number of medical procedures, advancements in disinfection technologies, and the increasing need for reliable sterilization solutions in critical sectors.

The liquid form segment of ortho phthalaldehyde generated USD 3.4 billion in 2024, making it the preferred choice for large-scale disinfection processes across multiple industries. Its stability and ease of use, combined with high effectiveness in medical sterilization and a lower toxicity profile, contribute to its widespread adoption. Industries favor liquid formulations for their ability to deliver quick microbial elimination with minimal environmental impact. While the powder form holds a smaller market share, its demand is gradually increasing due to niche applications that require dry formulations. The versatility of these formulations ensures their relevance across diverse industrial applications.

Products with a purity level of >=99% accounted for 65.2% of the market share in 2024, reflecting their superior performance in medical sterilization and protein detection. These high-purity variants are highly valued for their precision and reliability, particularly in sensitive environments such as hospitals and research institutions. Their minimal residual contamination ensures safety and efficacy, making them the preferred choice for critical applications. Meanwhile, products with a 99% purity level cater to less demanding applications where ultra-high purity is not essential. The preference for higher purity formulations highlights the increasing demand for dependable sterilization solutions in sectors where hygiene and accuracy are non-negotiable.

The US ortho phthalaldehyde market generated USD 1.7 billion in 2024, driven by its extensive use in healthcare, particularly for sterilizing medical instruments. Stringent regulatory standards governing infection control and surgical procedures are fueling demand for this compound. Manufacturers are focusing on advanced formulations to optimize both efficacy and safety, ensuring compliance with safety guidelines. The growing emphasis on infection prevention and the adoption of high-purity ortho phthalaldehyde solutions are further supporting market expansion. With ongoing advancements in disinfection technology and the increasing number of medical procedures, the US market is expected to witness sustained growth in the coming years.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Supplier landscape
• 3.3 Profit margin analysis
• 3.4 Key news & initiatives
• 3.5 Regulatory landscape
• 3.6 Impact forces
  • 3.6.1 Growth drivers
    • 3.6.1.1 Increased healthcare and medical facilities
    • 3.6.1.2 Expanding pharmaceutical industry
    • 3.6.1.3 Increased chemical industry usage
  • 3.6.2 Industry pitfalls & challenges
    • 3.6.2.1 Regulatory challenges
• 3.7 Growth potential analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Form, 2021-2034 (USD Billion, Kilo Tons)

• 5.1 Key trends
• 5.2 Liquid
• 5.3 Powder

Chapter 6 Market Size and Forecast, By Purity, 2021-2034 (USD Billion, Kilo Tons)

• 6.1 Key trends
• 6.2 <99%
• 6.3 ≥99%

Chapter 7 Market Size and Forecast, By Application, 2021-2034 (USD Billion, Kilo Tons)

• 7.1 Key trends
• 7.2 Medical disinfection
• 7.3 Protein detection
• 7.4 Photoresist
• 7.5 Others

Chapter 8 Market Size and Forecast, By Region, 2021-2034 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Advanced Sterilization Products
• 9.2 Ataman Kimya
• 9.3 Garonit Pharmaceutical
• 9.4 Lircon
• 9.5 MedPurest
• 9.6 MP Biomedicals
• 9.7 RX Chemicals
• 9.8 Sigma-Aldrich
• 9.9 TCI America
• 9.10 Voda Chemicals
• 9.11 VWR International